Patchup

Radhika Rajpal is Season 4's most internationally credentialled female founder. Her career trajectory reads like a global business masterclass: Economics at Lady Shri Ram College (one of India's most prestigious women's colleges), INSEAD (world's top business school), AVP roles at Barclays and Microsoft in London, co-founding a Techstars-backed FinTech startup in London, and hosting the podcast "We Are Not Even That Successful" exploring entrepreneurial journeys. The founding story was deeply personal: after returning to India from Europe, Radhika discovered that several supplements she had been consuming contained ingredients that were banned in the US and Europe. This revelation, from a fitness enthusiast who scrutinised every label, triggered a mission to create India's cleanest possible supplement delivery system.

Patch Up Health delivers vitamins and minerals through transdermal patches, a delivery method considered one of the cleanest in pharmaceutical science because it requires zero oral additives. Unlike pills (which need binders, fillers, and coatings), gummies (which need sugar, flavours, and colours), and powders (which need sweeteners and mixing agents), a transdermal patch contains only the active nutrient, making it the purest possible supplement format. The science uses the 500 Dalton Rule: only molecules weighing less than 500 Daltons can pass through the skin barrier into the bloodstream. Patch Up formulates its patches with vitamins that meet this molecular weight threshold, ensuring genuine transdermal absorption rather than merely sitting on the skin surface.

Amount Asked: ₹50 lakhs Equity Offered: 1.75% Implied Pre-Money Valuation: ₹28.5 crore

Radhika walked into Season 4 Episode 15 with the most scientifically articulate health-tech pitch of the episode. Her opening tagline ("Goliyon ke saath Breakup" — Breakup with pills) immediately communicated Patch Up's positioning: a complete replacement for oral supplements through transdermal technology. She explained the science: the 500 Dalton Rule, transdermal absorption mechanics, the 8-hour wear time, body heat activation, and the zero-additive formulation. She shared her personal health journey from Europe to India and the shocking discovery of banned ingredients in Indian supplements.

Anupam Mittal was the most enthusiastically supportive Shark, calling Radhika "one of the best founders" he had encountered on Shark Tank India. Namita Thapar delivered the most pharmacologically informed critique: without clinical trials, transdermal vitamin efficacy claims cannot be scientifically validated, and making unproven health claims "can cause massive damage to your reputation." Aman Gupta shared concerns about the supplements industry's challenges and the lack of clinical trials. He did not invest. Ritesh Agarwal offered ₹50 lakhs for 5% equity (₹10 crore valuation). His OYO distributed deployment expertise was less strategically relevant for a D2C health product. Peyush Bansal offered ₹40 lakhs for 2.25% equity. His offer provided less capital than Anupam's at similar equity terms.

Season 4 Episode 15's most scientifically debated three-offer negotiation. Radhika asked ₹50L for 1.75% (₹28.5 crore). Ritesh offered ₹50L for 5% (₹10 crore). Peyush offered ₹40L for 2.25%. Anupam offered ₹50L for 2.27% (₹22 crore). Namita and Aman exited on clinical trial concerns. Radhika chose Anupam's offer: full capital at the highest valuation among competing offers, from the Shark who praised her as "one of the best founders" and whose Shaadi.com consumer platform expertise was applicable to scaling a D2C health brand.

Radhika Rajpal accepted Anupam Mittal's offer of ₹50 lakhs for 2.27% equity, valuing Patch Up at ₹22 crore. Anupam's consumer platform scaling expertise (Shaadi.com), his personal conviction in the founder, and his willingness to invest despite Namita's clinical trial warning demonstrated the specific risk tolerance that early-stage health innovation requires. The deal valued Patch Up 23% below Radhika's ask (₹22 crore versus ₹28.5 crore) but provided her ideal Shark: the investor most publicly enthusiastic about her capabilities.

Patch Up Health's post-Shark Tank trajectory validates Anupam's conviction. Inc42 featured a comprehensive company profile in August 2025 revealing impressive metrics: ₹4.2 crore revenue in the first year of operations (founded July 2024), 50,000 plus users, and strong traction driven significantly by the Shark Tank appearance. "Founded by Radhika Rajpal and Raghav Gandotra in July 2024, Gurugram-based Patch Up Health focuses on delivering nutrients, vitamins and minerals through transdermal patches that absorb through the skin. It offers clean, additive-free, sugar-free and filler-free patches designed for steady and effective nutrient delivery." The company's expansion roadmap is ambitiously multi-category: beyond vitamin patches, Patch Up plans to enter beauty patches , pain management patches, and wearable tech integrations .